[Chronic hepatitis treated with alpha-interferon].
The newest results on the interferon treatment of chronic viral hepatitis on the ground of controlled trials are reported. In chronic type B hepatitis about 35 percent of patients, while in chronic type C hepatitis 80 percent of patients showed good response, though in the latter disease relapse is frequent following the stop of interferon treatment. In hepatitis Delta infection further therapeutic studies are warranted. The duration of the interferon treatment in chronic viral hepatitis is still an unsolved question.
Michael
M
M
Institut f. Angewandte u. Experimentelle Onkologie, Universität Wien, Austria.
D002908:Chronic Disease; D004341:Drug Evaluation; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006511:Hepatitis B Antigens / Q000276:immunology; D006526:Hepatitis C / Q000188:drug therapy*; D003699:Hepatitis D / Q000188:drug therapy / Q000276:immunology; D006521:Hepatitis, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*
D006511:Hepatitis B Antigens; D016898:Interferon-alpha
A krónikus hepatitis kezelése alfa-interferonnal.